The Prevention of Hospital Readmissions in Heart Failure.
暂无分享,去创建一个
[1] C. Yancy,et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. , 2010, JAMA.
[2] J. Fleg,et al. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. , 2014, The American journal of medicine.
[3] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.
[4] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[5] Leora I. Horwitz,et al. Medication Reconciliation Accuracy and Patient Understanding of Intended Medication Changes on Hospital Discharge , 2012, Journal of General Internal Medicine.
[6] Steven H. Landers,et al. Mini-cog performance: novel marker of post discharge risk among patients hospitalized for heart failure. , 2014, Circulation. Heart failure.
[7] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[8] J. McMurray,et al. Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat Hospitalizations , 2012, Circulation.
[9] M. Borggrefe,et al. Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure , 2011, Circulation.
[10] Laura G. Qualls,et al. Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter-Defibrillator Versus Defibrillator Therapy Alone , 2014, Annals of Internal Medicine.
[11] B. Waterman,et al. Adding socioeconomic data to hospital readmissions calculations may produce more useful results. , 2014, Health affairs.
[12] Melissa M Deer,et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. , 2001, The American journal of medicine.
[13] Leora I. Horwitz,et al. Association of Discharge Summary Quality With Readmission Risk for Patients Hospitalized With Heart Failure Exacerbation , 2015, Circulation. Cardiovascular quality and outcomes.
[14] A. Jha,et al. Who Has Higher Readmission Rates for Heart Failure, and Why?: Implications for Efforts to Improve Care Using Financial Incentives , 2011, Circulation. Cardiovascular quality and outcomes.
[15] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.
[16] Harlan M Krumholz,et al. Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study , 2015, BMJ : British Medical Journal.
[17] Amanda H. Salanitro,et al. Risk prediction models for hospital readmission: a systematic review. , 2011, JAMA.
[18] T. Therneau,et al. Hospitalizations after heart failure diagnosis a community perspective. , 2009, Journal of the American College of Cardiology.
[19] D. Mozaffarian,et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.
[20] P. Austin,et al. Outcomes in patients with heart failure treated in hospitals with varying admission rates: population-based cohort study , 2014, BMJ quality & safety.
[21] A. Jha,et al. A path forward on Medicare readmissions. , 2013, The New England journal of medicine.
[22] S. Normand,et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. , 2010, JAMA.
[23] M. Vaduganathan,et al. Drug therapy to reduce early readmission risk in heart failure: ready for prime time? , 2013, JACC. Heart failure.
[24] Carol R Horowitz,et al. Effects of Nurse Management on the Quality of Heart Failure Care in Minority Communities , 2006, Annals of Internal Medicine.
[25] E John Orav,et al. The relationship between hospital admission rates and rehospitalizations. , 2011, The New England journal of medicine.
[26] L. Stevenson,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.
[27] S. Najjar,et al. Hospital readmission in heart failure, a novel analysis of a longstanding problem , 2015, Heart Failure Reviews.
[28] R. Bhalla,et al. Could Medicare Readmission Policy Exacerbate Health Care System Inequity? , 2010, Annals of Internal Medicine.
[29] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[30] Mark V. Williams,et al. Interventions to Reduce 30-Day Rehospitalization: A Systematic Review , 2011, Annals of Internal Medicine.
[31] A. Jha,et al. The Association Between Hospital Volume and Processes, Outcomes, and Costs of Care for Congestive Heart Failure , 2011, Annals of Internal Medicine.
[32] Graham Ingalsbe,et al. Neighborhood Socioeconomic Disadvantage and 30-Day Rehospitalization , 2015 .
[33] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.
[34] Leora I. Horwitz,et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.
[35] G. Fonarow,et al. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. , 2009, Journal of the American College of Cardiology.
[36] V. Hasselblad,et al. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. , 2004, Journal of the American College of Cardiology.
[37] Haya R Rubin,et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. , 2004, JAMA.
[38] D. Nerenz,et al. Socioeconomic status and readmissions: evidence from an urban teaching hospital. , 2014, Health affairs.
[39] S. Schneeweiss,et al. Repeated hospitalizations predict mortality in the community population with heart failure. , 2007, American heart journal.
[40] Robert A Berenson,et al. Medicare's readmissions-reduction program--a positive alternative. , 2012, The New England journal of medicine.
[41] Laura G. Qualls,et al. Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction. , 2012, JAMA.
[42] Maulik S Joshi,et al. Community factors and hospital readmission rates. , 2015, Health services research.
[43] H. Krumholz,et al. Telemonitoring in patients with heart failure. , 2010, The New England journal of medicine.
[44] K. Swedberg,et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. , 2013, European heart journal.
[45] Harlan M Krumholz,et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. , 2013, JAMA.
[46] Dylan S. Small,et al. Hospitals with higher nurse staffing had lower odds of readmissions penalties than hospitals with lower staffing. , 2013, Health affairs.
[47] Robert O. Bonow,et al. Rehospitalization for heart failure: problems and perspectives. , 2013, Journal of the American College of Cardiology.
[48] R. Carney,et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.
[49] Carl van Walraven,et al. A meta-analysis of hospital 30-day avoidable readmission rates. , 2012, Journal of evaluation in clinical practice.
[50] Harlan M. Krumholz,et al. Hospital Strategies Associated With 30-Day Readmission Rates for Patients With Heart Failure , 2013, Circulation. Cardiovascular quality and outcomes.
[51] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[52] Mark D. Huffman,et al. AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .
[53] Harlan M Krumholz,et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. , 2002, Journal of the American College of Cardiology.
[54] Nancy M Albert,et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. , 2007, JAMA.
[55] Steven H. Landers,et al. Mini-Cog PerformanceCLINICAL PERSPECTIVE , 2015 .